Piramal Pharma Limited (PPLPHARMA) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹245.3 (-0.37% day change)
Key ratios
- P/B ratio
- 2.22
- ROE (%)
- -3.99
- ROCE (%)
- 0.68
- Debt/Equity
- 0.7
- Dividend yield (%)
- 0.1
- Market cap (₹ Cr)
- 32,528.85
Forensic checks
Piotroski F-Score: 2/9 · Altman Z-Score: 5.05 · Beneish M-Score: -2.74
InvestSights quality score
59.4/100 — Average (descriptive data-driven composite; not a recommendation)
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.